DexCom Inc. | Lobbying Expenditures Disclosure at DexCom Inc.

Status
Filed
AGM date
Previous AGM date
Proposal number
5
Resolution details
Company ticker
DXCM
Lead filer
Individual
Resolution ask
Report on or disclose
ESG theme
  • Governance
ESG sub-theme
  • Lobbying / political engagement
Type of vote
Shareholder proposal
Filer type
Shareholder
Company sector
Health Care
Company HQ country
United States
Resolved clause
Resolved, Shareholders request that the DexCom provide a report, updated semiannually, disclosing the Company’s:
1. Policies and procedures for making, with corporate funds or assets, contributions and expenditures (direct or indirect) to (a) participate
or intervene in any campaign on behalf of (or in opposition to) any candidate for public office, or (b) influence the general public, or any
segment thereof, with respect to an election or referendum.
2. Monetary and non-monetary contributions and expenditures (direct and indirect) used in the manner described in section 1 above,
including:
a. The identity of the recipient as well as the amount paid to each; and
b. The title(s) of the person(s) in the Company responsible for decision-making.
The report shall be presented to the board of directors or relevant board committee and posted on the Company’s website within 12 months from
the date of the annual meeting. This proposal does not encompass lobbying spending.
Supporting statement
Supporting Statement
As a long-term shareholder of DexCom, I support transparency and accountability in corporate electoral spending. This includes any activity
considered intervention in a political campaign under the Internal Revenue Code, such as direct and indirect contributions to political candidates,
parties, or organizations, and independent expenditures or electioneering communications on behalf of federal, state, or local candidates.
A company’s reputation, value, and bottom line can be adversely impacted by political spending. The risk is especially serious when giving to
trade associations, Super PACs, 527 committees, and “social welfare” organizations – groups that routinely pass money to or spend on behalf of
candidates and political causes that a company might not otherwise wish to support.
The Conference Board’s 2021 “Under a Microscope” report details these risks, recommends the process suggested in this proposal, and warns
“a new era of stakeholder scrutiny, social media, and political polarization has propelled corporate political activity – and the risks that come with
it – into the spotlight. Political activity can pose increasingly significant risks for companies, including the perception that political contributions –
and other forms of activity – are at odds with core company values.”
This proposal asks DexCom to disclose all of its electoral spending, including payments to trade associations and other tax-exempt
organizations which may be used for electoral purposes–and are otherwise undisclosed. This would bring our Company in line with a growing
number of 1eading companies, including Intuitive Surgical, Inc., AbbVie Inc., and Edwards Lifesciences Corporation, which present this
information on their websites.Without knowing the recipients of our company’s political dollars shareholders cannot sufficiently assess whether our company’s election-related
spending aligns or conflicts with its policies on climate change and sustainability, or other areas of concern. Thus it will be a best practice for
DexCom to expand its political spending disclosure.

Filed by John Chevedden

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.